Pera, V., Brusselle, G. G., Riemann, S., Kors, J. A., Van Mulligen, E. M., Parry, R., . . . Verhamme, K. M. C. (2023). Parasitic infections related to anti-type 2 immunity monoclonal antibodies: A disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS). Frontiers in pharmacology, 14, 1276340. https://doi.org/10.3389/fphar.2023.1276340
Chicago Style (17th ed.) CitationPera, Victor, Guy G. Brusselle, Sebastian Riemann, Jan A. Kors, Erik M. Van Mulligen, Rowan Parry, Marcel de Wilde, Peter R. Rijnbeek, and Katia M. C. Verhamme. "Parasitic Infections Related to Anti-type 2 Immunity Monoclonal Antibodies: A Disproportionality Analysis in the Food and Drug Administration’s Adverse Event Reporting System (FAERS)." Frontiers in Pharmacology 14 (2023): 1276340. https://doi.org/10.3389/fphar.2023.1276340.
MLA (9th ed.) CitationPera, Victor, et al. "Parasitic Infections Related to Anti-type 2 Immunity Monoclonal Antibodies: A Disproportionality Analysis in the Food and Drug Administration’s Adverse Event Reporting System (FAERS)." Frontiers in Pharmacology, vol. 14, 2023, p. 1276340, https://doi.org/10.3389/fphar.2023.1276340.